Wird geladen...
High expression of miR-9 in CD133(+) glioblastoma cells in chemoresistance to temozolomide
Glioblastoma Multiforme (GBM), a uniformly lethal stage IV astrocytoma, is currently treated with a combination of surgical and radiation therapy as well as Temozolomide (TMZ) chemotherapy. Resistance to TMZ is rapidly acquired by GBM cells and overcoming this resistance has been an area of signi?ca...
Gespeichert in:
| Veröffentlicht in: | J Cancer Stem Cell Res |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4917210/ https://ncbi.nlm.nih.gov/pubmed/27347493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14343/JCSCR.2015.3e1003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|